Head-to-head · WeighScore
Heally vs Kin Meds
The verdict
Kin Meds takes it — 72.9/100 to 70.9/100, but only just.
Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and… Heally is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Heally | Kin Meds |
|---|---|---|
| WeighScore | 70.9/100 | 72.9/100 |
| Grade | C | C |
| Scorecard rank | #100 | #73 |
| Semaglutide | $199/mo (starting dose, compounded) | $149/mo (brand Wegovy) |
| Tirzepatide | $299/mo (starting dose, brand-name) | $149/mo (brand Zepbound) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #100 · C
Strengths
- Broad GLP-1 menu: semaglutide, tirzepatide and liraglutide (branded or compounded)
- LegitScript verified; care provided by HLY Medical Group PA
- Semaglutide from ~$199/mo with a $100-off first-month promotion
- Medications ship from licensed, state-regulated pharmacies with free shipping
- Available in almost every state (excluding Alaska and DC)
Where it loses points
- Compounded medications are not FDA-evaluated for safety, efficacy or quality
- Cash-pay; FSA/HSA acceptance not stated on the platform
- Some pricing routes through LillyDirect rather than Heally directly
- Specific list of supported states not consolidated for easy review
Graded #73 · C
Strengths
- Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- LegitScript verified
- Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
Where it loses points
- Legal entity name and state of incorporation not publicly disclosed
- The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- Per-state availability not listed
- $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- Lab work and dose-titration support not clearly described
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.